Legal status · Canada
Is Kisspeptin-54 legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Kisspeptin-54 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Kisspeptin-54 in Canada at a glance
| Classification | Investigational, not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada; investigational |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Kisspeptin-54 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Kisspeptin-54 is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Kisspeptin-54 is
Genuinely good randomised human evidence, all of it about triggering egg maturation in IVF: oocyte maturation in 95% of 60 women at high risk of ovarian hyperstimulation syndrome, with no moderate, severe or critical cases. Chronic dosing causes tachyphylaxis, a randomised trial found no effect on anxiety, and chronic subcutaneous dosing caused testicular degeneration in adult male rats.
Kisspeptin-54 is one of the better-evidenced compounds on this site, and the evidence points somewhere very specific that has almost nothing to do with how it is sold. It is the 54 residue product of the KISS1 gene, acting at KISS1R upstream of GnRH neurons.
Mechanism: Demonstrated in humans, not proposed. Kisspeptin-54 binds KISS1R, formerly GPR54, on hypothalamic GnRH neurons, triggering release of an endogenous pool of GnRH, which drives pituitary luteinising hormone and follicle-stimulating hormone secretion.
Regulatory history: Investigational. No approved kisspeptin product exists in any jurisdiction. The IVF trigger work is phase 2 and has not been taken to a registrational phase 3 programme.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Kisspeptin-54 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Kisspeptin-54 in other countries
Frequently asked questions
Is Kisspeptin-54 legal in Canada?
No. Kisspeptin-54 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Can I buy Kisspeptin-54 in Canada?
No approved product exists to buy. In Canada Kisspeptin-54 is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Kisspeptin-54 Health Canada approved?
No. In Canada Kisspeptin-54 is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational. No approved kisspeptin product exists in any jurisdiction. The IVF trigger work is phase 2 and has not been taken to a registrational phase 3 programme.. On the evidence, 5 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Kisspeptin-54 live on its compound profile.
Kisspeptin-54 profileThis page is general information about the regulatory status of Kisspeptin-54 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.